Swedbank Ab Personalis, Inc. Transaction History

Swedbank Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 09, 2024	SELL	$1.78 - $3.64 $712,445 - $1.46 Million	-400,250 Closed	0 $0
Q3 2022 Dec 09, 2024	SELL	$2.89 - $5.32 $3.03 Million - $5.59 Million	-1,050,000 Reduced 72.4%	400,250 $1.19 Million
Q2 2022 Dec 09, 2024	BUY	$3.27 - $8.76 $173,310 - $464,280	53,000 Added 3.79%	1,450,250 $5 Million
Q1 2022 Dec 09, 2024	BUY	$7.56 - $14.3 $378,000 - $715,000	50,000 Added 3.71%	1,397,250 $11.4 Million
Q4 2021 Dec 09, 2024	BUY	$12.24 - $21.25 $610,335 - $1.06 Million	49,864 Added 3.84%	1,347,250 $19.2 Million
Q3 2021 Dec 09, 2024	SELL	$16.69 - $26.05 $83 - $130	-5 Reduced -0.0%	1,297,386 $25 Million
Q2 2021 Dec 09, 2024	BUY	$18.15 - $27.75 $183,423 - $280,441	10,106 Added 0.79%	1,297,391 $32.8 Million
Q1 2021 Dec 09, 2024	BUY	$20.71 - $51.02 $26.7 Million - $65.7 Million	1,287,285 New	1,287,285 $31.7 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $280M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.